
Overview
Amerpharma provides private-label and white-label production of dietary supplements and functional food, including custom formulation, product development, contract manufacturing and liquid bottling. Its products include electrolyte concentrates, energy gels, zero-calorie syrups and matcha products; the company states it has 15 years of experience and more than 150 brand launches.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-12-31. Active
05 1020 1068 0000 1602 0233 1569
79 1020 4900 0000 8002 3073 6915
91 1020 1068 0000 1402 0327 8876
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
19 public aid cases recorded, with a total value of $361,216.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 28, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Jan 26, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Mar 29, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego |
European Funds
6 projects co-financed from European Funds recorded, with total EU co-financing of $507,431.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-11-01 | Przygotowanie do internacjonalizacji przedsiębiorstwa AmerPharma Sp. z o.o na nowe rynki zagraniczne. | $35,460$35,460 | Program Operacyjny Polska Wschodnia | |
| 2021-04-01 | Wypromowanie marki AMERPHARMA na rynkach Zatoki Perskiej. | $28,047$28,047 | Program Operacyjny Inteligentny Rozwój | |
| 2021-02-01 | Promocja marki i produktów Klement Real Estate na wybranych rynkach zagranicznych w celu zdobycia nowych rynków zbytu | $21,001$21,001 | Regionalny Program Operacyjny Województwa Lubelskiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the sole member of the management board has the right to represent the company. If the management board consists of two members, the President of the Management Board represents the company independently, while the member of the management board may do so only jointly with the President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 588 | $7,941.65 | 32.8859% | |
Humble Group Ab | 612 | $8,265.80 | 34.2282% |
| 588 | $7,941.65 | 32.8859% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Drnutssp. z o.o. | 1,350.62 USD | 50% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Natural Brandssp. z o.o. | $12,066,969.37 | naturalbrands.pl | ||
| Prowanasp. z o.o. | $11,678,856.98 | prowana.pl | ||
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | ||
| Mipama E.Z.Szafarzsp. j. | $8,744,759.24 | mipama.pl | ||
| Gofarmsp. z o.o. + limited partnership | $8,632,148.10 | gofarm.pl | ||
| Puwer Polskasp. z o.o. | $6,855,625.12 | puwer.pl | ||
| INV Polandsp. z o.o. | $6,811,226.32 | invpoland.com | ||
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-02-16 | PKD change (Removed: 46.46.Z) | |
| 2021-01-27 | Name change (Aperpharma → Amerpharma) | |
| 2021-01-11 | Name change (Klement → Aperpharma) | |
| 2021-01-11 | PKD change (Added: 46.38.Z, 70.22.Z) | |
| 2020-04-03 | Share capital change (50,000.00 PLN → 60,000.00 PLN) |
FAQ
Last updated: 2026-09-15




